Geneos Wealth Control Inc. grew its place in stocks of Johnson & Johnson (NYSE:JNJ – Loose Record) via 4.1% right through the third quarter, in step with its most up-to-date submitting with the Securities and Alternate Fee (SEC). The fund owned 36,970 stocks of the corporate’s inventory after buying an extra 1,448 stocks right through the length. Geneos Wealth Control Inc.’s holdings in Johnson & Johnson have been price $5,758,000 on the finish of the latest quarter.

Different hedge budget additionally lately changed their holdings of the corporate. Atlantic Personal Wealth LLC got a brand new stake in stocks of Johnson & Johnson right through the first quarter price about $32,000. FNY Funding Advisers LLC bought a brand new place in stocks of Johnson & Johnson right through the third quarter price about $37,000. VitalStone Monetary LLC bought a brand new place in stocks of Johnson & Johnson right through the 2d quarter price about $48,000. 25 LLC bought a brand new place in stocks of Johnson & Johnson right through the first quarter price about $55,000. In spite of everything, Horizons Wealth Control lifted its holdings in stocks of Johnson & Johnson via 1,730.0% right through the 2d quarter. Horizons Wealth Control now owns 366 stocks of the corporate’s inventory price $61,000 after obtaining an extra 346 stocks right through the length. 68.40% of the inventory is owned via institutional traders and hedge budget.

Johnson & Johnson Buying and selling Up 1.1 %

JNJ opened at $154.88 on Friday. Johnson & Johnson has a 52-week low of $144.95 and a 52-week top of $180.93. The corporate has a handy guide a rough ratio of 0.96, a present ratio of one.21 and a debt-to-equity ratio of 0.37. The company has a marketplace capitalization of $372.84 billion, a P/E ratio of eleven.50, a P/E/G ratio of three.20 and a beta of 0.57. The company’s 50 day shifting reasonable is $152.42 and its 200-day shifting reasonable is $159.74.

Johnson & Johnson (NYSE:JNJ – Get Loose Record) remaining launched its quarterly income effects on Tuesday, October seventeenth. The corporate reported $2.66 income consistent with proportion for the quarter, topping analysts’ consensus estimates of $2.52 via $0.14. Johnson & Johnson had a web margin of 36.32% and a go back on fairness of 37.14%. The industry had earnings of $21.35 billion right through the quarter, in comparison to the consensus estimate of $21 billion. Analysts be expecting that Johnson & Johnson will submit 9.96 EPS for the present fiscal 12 months.

Johnson & Johnson Broadcasts Dividend

The company additionally lately introduced a quarterly dividend, which was once paid on Tuesday, December fifth. Shareholders of file on Tuesday, November twenty first have been issued a dividend of $1.19 consistent with proportion. The ex-dividend date of this dividend was once Monday, November twentieth. This represents a $4.76 dividend on an annualized foundation and a dividend yield of three.07%. Johnson & Johnson’s dividend payout ratio (DPR) is 35.34%.

Analyst Upgrades and Downgrades

A number of analysis analysts have lately weighed in on JNJ stocks. Wells Fargo & Corporate decreased stocks of Johnson & Johnson from an “obese” score to an “equivalent weight” score and minimize their worth function for the inventory from $170.00 to $163.00 in a file on Wednesday, December thirteenth. StockNews.com upgraded stocks of Johnson & Johnson from a “purchase” score to a “strong-buy” score in a file on Thursday, October twenty sixth. UBS Team upgraded stocks of Johnson & Johnson from a “impartial” score to a “purchase” score and raised their worth goal for the corporate from $167.00 to $180.00 in a file on Friday, December 1st. Raymond James minimize their worth goal on stocks of Johnson & Johnson from $179.00 to $172.00 and set an “outperform” score at the inventory in a file on Wednesday, October 18th. In spite of everything, Cantor Fitzgerald restated an “obese” score on stocks of Johnson & Johnson in a file on Monday. 8 analysis analysts have rated the inventory with a cling score, six have given a purchase score and one has issued a robust purchase score to the inventory. In response to information from MarketBeat.com, the inventory has a mean score of “Average Purchase” and a consensus worth goal of $168.75.

Learn Our Newest Inventory Research on JNJ

Johnson & Johnson Corporate Profile

(Loose Record)

Johnson & Johnson, along side its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being section supplies pores and skin well being/good looks merchandise underneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE emblem; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and hypersensitive reaction merchandise; BENADRYL and ZYRTEC hypersensitive reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disease merchandise.

See Additionally

Obtain Information & Scores for Johnson & Johnson Day-to-day – Input your e-mail cope with underneath to obtain a concise day by day abstract of the newest information and analysts’ scores for Johnson & Johnson and comparable corporations with MarketBeat.com’s FREE day by day e-mail publication.